Erectile Dysfunction after Transuretheral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia
Article Sidebar
Main Article Content
Abstract
Background: Benign prostatic hyperplasia (BPH) is commonly associated with lower urinary tract symptoms (LUTS) in aging men, which can significantly impact their quality of life. Transurethral resection of the prostate (TURP) is a standard treatment for BPH, yet its effects on erectile function remain controversial.
Objective: To assess the impact of TURP on erectile function in patients with BPH and to evaluate the potential relationship between the relief of obstructive urinary symptoms and changes in erectile function postoperatively.
Methods: This single-center, non-randomized study enrolled 177 male patients aged 50 to 80 years with a clinical diagnosis of BPH and an International Prostate Symptom Score (IPSS) greater than 8. Participants underwent monopolar TURP and were evaluated using the International Index of Erectile Function (IIEF-5) questionnaire one month post-surgery. Data were analyzed using SPSS version 21 with Chi-square tests applied to examine the influence of age and IPSS scores on erectile function, considering a p-value ≤0.05 as significant.
Results: The mean age of participants was 57.53 ± 6.96 years, and the mean resected prostate tissue weight was 122.82 ± 12.05 grams. Post-TURP, 44.6% of patients were found to have some degree of erectile dysfunction. However, no significant changes in erectile function were observed one month following TURP (p=0.602 for age, p=0.878 for IPSS score).
Conclusion: TURP did not significantly affect erectile function one month postoperatively in BPH patients with severe urinary symptoms. While some improvement in erectile function was noted, the results suggest that the benefits of TURP on erectile function may not be immediate. Further longitudinal studies with larger sample sizes are required to provide more definitive conclusions.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med. 1995;332: 75-9.
Shrivastava A, Gupta VB. Various treatment options for benign prostatic hyperplasia: a current update. J Mid-life health.2012 Jan; 3(1):10.
Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol. 2013 Jan; 189(1):102-6.
Reich O, Gratzke C, Bachmann A. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2012;180:246–9
Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F. The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol. 2011;29:205–10
Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z, et al. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. Br J Urol Int. 2010;106:1339–43
Omar MI, Lam TB, Alexander CE, Graham J, Mamoulakis C, Imamura M, et al. Systematic review and meta‐analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). Br J Urol Int. 2014 Jan; 113(1):24-35.
Taher A. Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors. World J Urol. 2004 Dec 1;22(6):457-60.
Roehrborn CG. Sexual function and benign prostatic hyperplasia. Rev Urol. 1999;1(3):157.
Bruskewitz RC. Quality of life and sexual function in patients with benign prostatic hyperplasia. Rev Urol. 2003;5(2):72.
Russo GI, Favilla V, Cimino S, Fragalà E, Salamone C, Castelli T, et al. 1234 Predictive factors of erectile dysfunction after TURP in potent patients. J Urol. 2013 Apr 1;189(4):e505.
Cha JS, Park JK. Association between lower urinary tract symptoms and erectile dysfunction. Korean J Urol. 2005;46:1023-7.
Skinder D, Zacharia I, Studin J, Covino J. Benign prostatic hyperplasia: A clinical review. J Am Acad of PAs. 2016 Aug 1;29(8):19-23.
Sausville J, Naslund M. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians. Int J Clin Pract 2010;64(13):1740-5.
Homma Y, Gotoh M, Yokoyama O. Outline of JUA clinical guidelines for benign prostatic hyperplasia. Int J Urol. 2011;18(11): 741-56.
Kapoor A. Benign prostatic hyperplasia (BPH) management in the primary care setting. Can J Urol. 2012; 19(suppl 1):10-7.
Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev in urol. 2005;7(Suppl 9):S3.
Roehrborn C, McConnell J. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh P, Retik A, Vaughan E, Wein A, eds. Campbell’s Urology. 8th ed. Philadelphia: Saunders; 2002:1297-336.
Girman CJ. Population-based studies of the epidemiology of benign prostatic hyperplasia. Br J Urol. 1998;82(suppl 1):34-43.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9.
Girman CJ, Panser LA, Chute CG. Natural history of prostatism: urinary flow rates in a community- based study. J Urol. 1993;150:887-92.
Abrams P. Objective evaluation of bladder outlet obstruction [review]. Br J Urol. 1995;76(suppl 1):11-5.
Girman CJ, Jacobsen SJ, Rhodes T. Association of health-related quality of life and benign prostatic enlargement. Eur Urol. 1999;35: 277-84.
Girman CJ, Jacobsen SJ, Tsukamoto T. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urol. 1998;51: 428-36.
Rosen R, Altwein J, Boyle P. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637-49.
United Nations. World Population Prospects: The 2002 Revision (medium scenario). New York: United Nations; 2003.
Ho CK, Habib FK. Estrogen and androgen signaling in the pathogenesis of BPH. Nat Rev Urol. 2011;8(1):29-41.
Sarma AV, Wei JT. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med. 2012;367(3):248-57.
Lee HW, Kim SA, Nam JW. The study about physical activity for subjects with prevention of benign prostate hyperplasia. Int Neurourol J. 2014;18(3):155-62.
Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212-8.
Dong Y, Hao L, Shi Z. Efficacy and safety of tadalafil monotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a meta-analysis. Urol Int. 2013;91(1):10-8.
Djavan B, Dianat SS, Kazzazi A. Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin. Patient Relat Outcome Meas. 2011;2:71-9.
Barry MJ, Fowler FJ, Jr, O’Leary MP. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549-57.
McVary KT, Roehrborn CG, Avins AL. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia. Chapter 1: guideline on the management of benign prostatic hyperplasia (BPH). https://www.auanet.org/education/ guidelines/benign-prostatic-hyperplasia.cfm. Accessed April 12, 2016.
Kim SB, Cho IC, Min SK. Prostate volume measurement by transrectal ultrasonography: comparison of height obtained by use of transaxial and midsagittal scanning. Korean J Urol. 2014;55(7): 470-4
American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American geriatrics society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-31.
37Barry MJ, Meleth S, Lee JY. Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011;306(12):1344-51.
Nickel JC, Méndez-Probst CE, Whelan TF, et al; and the Canadian Prostate Health Council and the CUA Guidelines Committee. 2010 Update: Guidelines for the management of benign prostatic hyperplasia. Can Urol Assoc J2010;4:310-6.
Roehrborn CG, McConnell JD, Barry MJ, et al. AUA Guideline on the management of benign prostatic hyperplasia. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm
De la Rosette J, Alivizatos G, Madersbacher S, et al. Guidelines on Benign Prostatic Hyperplasia. European Association of Urology 2006. http://www.uroweb.org/fileadmin/user_upload/Guidelines/11%20BPH.pdf.
Mebust WK, Holtgrewe HL, Cockett AT, et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243-7.
Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-9.
Reich O, Gratzke C, Bachmann A, et al; Urology Section of the Bavarian Working Group for Quality Assurance. . Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180:246-9. Epub 2008 May 21
Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83:227-37.
Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol2010;58:384-97. Epub 2010 Jun 11.
Borth CS, Beiko DT, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology 2001;57:1082-5.
Yu X, Elliott SP, Wilt TJ, et al. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180:241-5. Epub 2008 May 21.
Lynch M, Anson K. Time to rebrand transurethral resection of the prostate? Curr Opin Urol 2006;16:20-4.
Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials. Eur Urol Epub 2009 Jul 7
38Choi SB, Zhao C, Park JK. The effect of transurethral resection of the prostate on erectile function in patients with benign prostatic hyperplasia. Korean j urol. 2010 Aug 1; 51(8):557-60.
Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002;90: 836-9.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151: 54-61.
Ledda A. Cigarette smoking, hypertension and erectile dysfunction. Curr Med Res Opin 2000;16(Suppl 1):S13-6.
Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol 1987;137: 829-36.
Hanbury DC, Sethia KK. Erectile function following transurethral prostatectomy. Br J Urol 1995;75: 12-3.
Lindner A, Golomb J, Korczak D, Keller T, Siegel Y. Effects of prostatectomy on sexual function. Urology 1991;38: 26-8.
Soderdahl DW, Knight RW, Hansberry KL. Erectile dysfunction following transurethral resection of the prostate. J Urol 1996; 156:1354-6.
Miner M, Rosenberg MT, Perelman MA. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Ther 2006;28: 13-25.
Poulakis V, Ferakis N, Witzsch U, de Vries R, Becht E. Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500 patients. Asian J Androl 2006; 8:69-74.
Oh SY, Min KS, Choi SH. Effects of prostate volume and lower urinary tract symptoms on erectile function. Korean J Urol 2007;48:24-8.
Jaidane M, Arfa NB, Hmida W, Hidoussi A, Slama A, Sorba NB, Mosbah F. Effect of transurethral resection of the prostate on erectile function: a prospective comparative study. Int j impotence res. 2010 Mar;22(2):146.
Bieri S, Iselin CE, Rohner S. Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997; 31: 545–8.
Tscholl R, Largo M, Poppinghaus E, Recker F, Subotic B. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995; 153: 1491–3.
Ibrahim AI, El-Malik EM, Ismail G, Rashid M, Al Zahrani AB. Risk factors associated with sexual dysfunction after transurethral resection of the prostate. Ann Saudi Med 2002; 22: 8–12.
Coeurdacier P, Staerman F, Corbel L, Cipolla B, Guille F, Lobel B. Peut-on mieux faire que la chirurgie dans le traitement de l’hypertrophie be´nigne de prostate? les re´sultats a`10 ansde la re´section endoscopique et de l’ade´nomectomie sur les troubles mictionnels et la sexualite´. Progre`s en Urologie 1993; 3: 1016–23.
Zohar J, Meiraz D, Maoz B, Durst N. Factors influencing sexual activity after prostatectomy: a prospective study. J Urol 1976; 116: 332–4.
Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs R, Fourcade R et al. The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study. BJU Int 2003; 92: 719–25.
Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical ‘Aging Male’ symptoms? Results of the ‘Cologne Male Survey’. Eur Urol 2003; 44: 588–94.
Vallancien G, Emberton M, Harving N, van Moorselaar RJ. Sexual dysfunction in 1274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169: 2257–61.
Jung JH, Jae SU, Kam SC, Hyun JS. Correlation between lower urinary tract symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function. J Sex Med 2009; 6: 2299–304.